Latest news with #NavinFluorineInternational
&w=3840&q=100)
Business Standard
12-05-2025
- Business
- Business Standard
Navin Fluorine shares fall 3% post Q4 results: Here's what brokerages say
Navin Fluorine reported a revenue from operations of ₹700.94 crore in Q4 FY25, up 16.44 per cent year-on-year (Y-o-Y) from ₹601.95 crore in the year-ago period Devanshu Singla New Delhi Navin Fluorine International share price today: Shares of speciality fluorochemicals company Navin Fluorine International fell over 3 per cent to hit an intra-day low of ₹4,435 on Monday after the company reported its March 2025 quarter (Q4FY25) results. At 2:10 PM on Monday, Navin Flourine's stock was quoting at ₹4,444, down 3.3 per cent on the National Stock Exchange (NSE). In comparison, the benchmark Nifty50 index was trading at 24,842.25, up 834.25 points or 3.5 per cent. The stock reversed gains after hitting a 52-week high of ₹4,748 in today's trading session. The company's total market capitalisation stood at ₹22,030.47 crore. Navin Fluorine Q4 FY25 result update Navin Fluorine reported a revenue from operations of ₹700.94 crore in Q4 FY25, up 16.4 per cent year-on-year (Y-o-Y) from ₹601.95 crore in the year-ago period. The company's earnings before interest, tax, depreciation and amortisation (Ebitda) rose 62.4 per cent to ₹178.71 crore compared to ₹110.04 crore in the corresponding quarter of the previous fiscal. Ebitda margin improved 721 basis points (bps) to 25.5 per cent from 18.3 per cent. The company's profit after tax (PAT) came in at ₹94.98 crore, up 35 per cent from ₹70.38 crore in the year-ago period. According to the MOFSL report, with the increasing use of fluorine in the pharma and agro space, battery chemicals, and performance materials, the CDMO (Contract Development and Manufacturing Organisation) business of Navin Flourine is expected to grow at a compound annual growth rate (CAGR) of 53 per cent of over FY25-27. The company has already identified opportunities in its segments, such as a capability capex in speciality chemicals with ₹360 million in peak revenue, Fermion contract with a value of $30 million over three years, and a strategic agreement with Chemours to set up an initial commercial capacity for manufacturing of an innovative liquid cooling product, which is expected to be commissioned in Q1 FY27. Citing expensive valuations, the brokerage has maintained a 'Neutral' rating on the stock with a target price (TP) of ₹5,060. Axis Securities According to analysts at Axis Securities, Navin Fluorine continues to prioritise business expansion, enhancement of its technology capabilities, development of strategic partnerships and long-term sustainable growth. "While we acknowledge upside risks in terms of quicker-than-expected ramp-up in utilisation levels and contributions from new products, we believe the stock has already priced in most positives, and a further re-rating would depend on the successful execution and validation of growth initiatives," the brokerage said in a research note. Axis Securities has downgraded the stock from 'Buy' to 'Hold'; however, raised the target price to ₹4,440 from ₹4,300 earlier. PL Capital The brokerage firm says that the recent expansion of R-32 capacity by 5,000 mtpa was commercialised in March 2025 and is already operating at optimal utilisation levels. Additionally, the ongoing capex for AHF (Anhydrous Hydrogen Fluoride) is on track for commissioning by the September 2026 quarter (Q2 FY26). The company's speciality chemicals segment remained flat Y-o-Y, with both the Dahej and Surat facilities running at optimal capacity. According to the research note, the company management has indicated strong order visibility for FY26, with two new molecules scheduled to begin commercial supplies in Q1 FY26. "We believe long-term fundamentals of the company are intact. The strong order pipeline, expanding capacity, and improving realisations are expected to be key growth drivers going forward," the brokerage said. It has maintained an 'Accumulate' rating on the stock. Established in 1967, Navin Fluorine International is one of the largest speciality fluorochemical manufacturers in India. It is primarily engaged in the production of refrigeration gases, inorganic fluorides, speciality organofluorines and offers contract research and manufacturing services. The company's portfolio includes more than 50 fluorinated compounds with manufacturing facilities in Surat and Dahej in Gujarat and Dewas in Madhya Pradesh. Its Surat facility specialises in the manufacturing of refrigerants, various organic and inorganic fluorides.
Business Standard
12-05-2025
- Business
- Business Standard
Navin Fluorine Intl Q4 PAT rises 35% YoY to Rs 95 cr; declares dividend of Rs 7/sh
Navin Fluorine International's consolidated net profit jumped 34.95% to Rs 94.98 crore in Q4 FY25, compared with Rs 70.38 crore in Q4 FY24. Revenue from operations rallied 16.44% year on year to Rs 700.94 crore in Q4 FY25, compared with Rs 601.95 crore in Q4 FY24. Profit before tax (PBT) increased 59.93% YoY to Rs 127.02 crore in Q4 FY25. Operating EBITDA stood at Rs 178.71 crore in Q4 FY25, registering the growth of 62.39% compared with Rs 110.05 crore in corresponding quarter last year. EBITDA margin improved by 721 Bps to 25.50% in Q4 FY25 as against 18.28% in Q4 FY24. Revenue from high-performance product (HPP) jumped 10% YoY to Rs 326 crore during the quarter. The growth was driven by higher volumes and improved realizations. Revenue from specialty chemicals increased 1% YoY to Rs 259 crore in Q4 FY25 with optimal capacity utilization at Dahej & Surat with strong order visibility for FY26. The company said that the 2 new molecules planned supplies to begin in Q1FY26. In Q4 FY25, revenue from contract development and manufacturing organization (CDMO) zoomed 141% YoY to Rs 115 crore. Meanwhile, the board of directors has recommended final dividend of Rs 7 per equity share of the face value of Rs 2 each for the financial year 2024-2025 subject to approval of the members of the company at the forthcoming 27 the annual general meeting to be held on 31 July 2025. Navin Fluorine International belongs to a reputed industrial house of Padmanabh Mafatlal Group in India. It has largest integrated fluorochemicals complex in India. The company primarily focuses on fluorine chemistry - producing refrigeration gases, chemicals, inorganic bulk fluorides, specialty organofluorines and offers Contract Research and manufacturing services. Shares of Navin Fluorine International shed 0.19% to currently trade at Rs 4,572.90 on the BSE.
Business Standard
10-05-2025
- Business
- Business Standard
Navin Fluorine International consolidated net profit rises 34.94% in the March 2025 quarter
Sales rise 16.44% to Rs 700.94 crore Net profit of Navin Fluorine International rose 34.94% to Rs 94.96 crore in the quarter ended March 2025 as against Rs 70.37 crore during the previous quarter ended March 2024. Sales rose 16.44% to Rs 700.94 crore in the quarter ended March 2025 as against Rs 601.95 crore during the previous quarter ended March 2024. For the full year,net profit rose 6.68% to Rs 288.58 crore in the year ended March 2025 as against Rs 270.50 crore during the previous year ended March 2024. Sales rose 13.77% to Rs 2349.38 crore in the year ended March 2025 as against Rs 2065.01 crore during the previous year ended March 2024. Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 700.94601.95 16 2349.382065.01 14 OPM % 25.5018.28 - 22.7219.29 - PBDT 162.28105.13 54 499.52379.57 32 PBT 127.0279.42 60 380.09283.41 34 NP 94.9670.37 35 288.58270.50 7
Business Standard
09-05-2025
- Business
- Business Standard
Board of Navin Fluorine International approves fund raising up to Rs 750 cr
At meeting held on 09 May 2025The Board of Navin Fluorine International at its meeting held on 09 May 2025 has approved fund raising up to Rs 750 crore by way of issuance of equity shares or any other instruments or securities through qualified institutional placement / private placement / public issue / preferential issue or through any other permissible mode or combination thereof. Powered by Capital Market - Live News
Business Standard
07-05-2025
- Business
- Business Standard
Navin Fluorine inks pact with Chemours Company to manufacture new liquid cooling product
Navin Fluorine International said that it has entered into a strategic agreement with The Chemours Company to manufacture and establish initial capacity of Opteon two-phase immersion cooling fluid at Surat. Opteon is a proprietary product of Chemours Company. This product addresses the growing demands of advanced data centers and AI hardware for high performance, sustainable and cost-effective cooling solutions. The product aims to deliver significant energy efficiency, reduced water requirements as well as a materially lower physical footprint for data centres. Under the agreement, Navin Fluorine will establish manufacturing facility at Surat, Gujarat, at an estimated capex of $14 million (approximately Rs 120 crore), including $5 million (nearly Rs 43 crore) of contribution by Chemours. Navin would fund this capex through a mix of debt and internal accruals. The project is expected to be operational during Q1 FY27 (April 2026 to June 2026). As market adoption deepens, Navin Fluorine and Chemours will get into discussions for servicing a potentially higher demand. Vishad Mafatlal, executive chairman, Navin Fluorine, said: "Joining forces with Chemours to manufacture their new liquid cooling technology advances our mission to produce high-quality, innovative, and sustainable, high-growth-potential products in the specialty chemicals sector, while helping address a key industry challenge for data centers. Were excited to see this project come to fruition and look forward to continuing to deepen our partnership to meet the needs of the broader industry." Navin Fluorine International belongs to a reputed industrial house of Padmanabh Mafatlal Group in India. It has largest integrated fluorochemicals complex in India. The company primarily focuses on fluorine chemistry - producing refrigeration gases, chemicals, inorganic bulk fluorides, specialty organofluorines and offers contract research and manufacturing services. The company's consolidated net profit rose 7.15% to Rs 83.60 crore on a 21.21% increase in revenue to Rs 606.20 crore in Q3 FY25 over Q3 FY24. The scrip advanced 0.37% to currently trade at Rs 4637 on the BSE.
